BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30649797)

  • 1. Identification of Driver Genes and Key Pathways of Ependymoma.
    Zhong S; Yan Q; Ge J; Dou G; Xu H; Zhao G
    Turk Neurosurg; 2024; 34(2):184-195. PubMed ID: 30649797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of key methylation differentially expressed genes in posterior fossa ependymoma based on epigenomic and transcriptome analysis.
    Wang G; Jia Y; Ye Y; Kang E; Chen H; Wang J; He X
    J Transl Med; 2021 Apr; 19(1):174. PubMed ID: 33902636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of biomarkers and construction of a microRNA-mRNA regulatory network for ependymoma using integrated bioinformatics analysis.
    Yang B; Dai JX; Pan YB; Ma YB; Chu SH
    Oncol Lett; 2019 Dec; 18(6):6079-6089. PubMed ID: 31788082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examining the biomarkers and molecular mechanisms of medulloblastoma based on bioinformatics analysis.
    Yang B; Dai JX; Pan YB; Ma YB; Chu SH
    Oncol Lett; 2019 Jul; 18(1):433-441. PubMed ID: 31289514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Driver Genes and Key Pathways of Pediatric Brain Tumors and Comparison of Molecular Pathogenesis Based on Pathologic Types.
    Zhong S; Wu B; Han Y; Cao Y; Yang L; Luo SX; Chen Y; Zhang H; Zhao G
    World Neurosurg; 2017 Nov; 107():990-1000. PubMed ID: 28751139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a five genes prognosis signature for triple-negative breast cancer using multi-omics methods and bioinformatics analysis.
    Ma J; Chen C; Liu S; Ji J; Wu D; Huang P; Wei D; Fan Z; Ren L
    Cancer Gene Ther; 2022 Nov; 29(11):1578-1589. PubMed ID: 35474355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Driver Genes and Key Pathways of Glioblastoma Shows JNJ-7706621 as a Novel Antiglioblastoma Drug.
    Zhong S; Wu B; Dong X; Han Y; Jiang S; Zhang Y; Bai Y; Luo SX; Chen Y; Zhang H; Zhao G
    World Neurosurg; 2018 Jan; 109():e329-e342. PubMed ID: 28989042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of key candidate genes and biological pathways in bladder cancer.
    Gao X; Chen Y; Chen M; Wang S; Wen X; Zhang S
    PeerJ; 2018; 6():e6036. PubMed ID: 30533316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of hub genes and pathways in adrenocortical carcinoma by integrated bioinformatic analysis.
    Guo J; Gu Y; Ma X; Zhang L; Li H; Yan Z; Han Y; Xie L; Guo X
    J Cell Mol Med; 2020 Apr; 24(8):4428-4438. PubMed ID: 32147961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of key genes and pathways involved in trastuzumab-resistant gastric cancer.
    Yu C; Xue P; Zhang L; Pan R; Cai Z; He Z; Sun J; Zheng M
    World J Surg Oncol; 2018 Aug; 16(1):174. PubMed ID: 30134903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data.
    Vastrad B; Vastrad C; Godavarthi A; Chandrashekar R
    Med Oncol; 2017 Sep; 34(11):182. PubMed ID: 28952134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of key pathways and genes in colorectal cancer using bioinformatics analysis.
    Liang B; Li C; Zhao J
    Med Oncol; 2016 Oct; 33(10):111. PubMed ID: 27581154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
    Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
    Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive analysis and identification of key genes and signaling pathways in the occurrence and metastasis of cutaneous melanoma.
    Dai H; Guo L; Lin M; Cheng Z; Li J; Tang J; Huan X; Huang Y; Xu K
    PeerJ; 2020; 8():e10265. PubMed ID: 33240619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bioinformatics analysis of core differentially expressed genes in hepatitis B virus-related hepatocellular carcinoma].
    Yu Y; Cheng J; Mei CZ; Dai YZ
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2022 Nov; 34(5):507-513. PubMed ID: 36464255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of genes predicting unfavorable prognosis in hepatitis B virus-associated hepatocellular carcinoma.
    Sha M; Cao J; Zong ZP; Xu N; Zhang JJ; Tong Y; Xia Q
    Ann Transl Med; 2021 Jun; 9(12):975. PubMed ID: 34277775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression patterns combined with network analysis identify hub genes associated with bladder cancer.
    Bi D; Ning H; Liu S; Que X; Ding K
    Comput Biol Chem; 2015 Jun; 56():71-83. PubMed ID: 25889321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Multiple Hub Genes and Pathways in Hepatocellular Carcinoma: A Bioinformatics Analysis.
    Liu J; Han F; Ding J; Liang X; Liu J; Huang D; Zhang C
    Biomed Res Int; 2021; 2021():8849415. PubMed ID: 34337056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Potential Crucial Genes and Key Pathways in Breast Cancer Using Bioinformatic Analysis.
    Deng JL; Xu YH; Wang G
    Front Genet; 2019; 10():695. PubMed ID: 31428132
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of key target genes and biological pathways in multiple sclerosis brains using microarray data obtained from the Gene Expression Omnibus database.
    Zheng W; Chen Y; Chen H; Xiao W; Liang Y; Wang N; Jiang X; Wen S
    Neurol Res; 2018 Oct; 40(10):883-891. PubMed ID: 30074468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.